Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Gains from Investment Securities (2020 - 2025)

iSpecimen has reported Gains from Investment Securities over the past 6 years, most recently at $73180.0 for Q4 2025.

  • Quarterly results put Gains from Investment Securities at $73180.0 for Q4 2025, up 9815.99% from a year ago — trailing twelve months through Dec 2025 was $73180.0 (down 65.36% YoY), and the annual figure for FY2025 was $73180.0, down 88.21%.
  • Gains from Investment Securities for Q4 2025 was $73180.0 at iSpecimen, roughly flat from $73084.0 in the prior quarter.
  • Over the last five years, Gains from Investment Securities for ISPC hit a ceiling of $350062.0 in Q1 2024 and a floor of $738.0 in Q4 2024.
  • Median Gains from Investment Securities over the past 5 years was $95340.0 (2024), compared with a mean of $149459.4.
  • Peak annual rise in Gains from Investment Securities hit 9815.99% in 2025, while the deepest fall reached 98.56% in 2025.
  • iSpecimen's Gains from Investment Securities stood at $165463.0 in 2021, then decreased by 0.81% to $164131.0 in 2022, then plummeted by 90.82% to $15075.0 in 2023, then plummeted by 95.1% to $738.0 in 2024, then skyrocketed by 9815.99% to $73180.0 in 2025.
  • The last three reported values for Gains from Investment Securities were $73180.0 (Q4 2025), $73084.0 (Q3 2025), and $72148.0 (Q2 2025) per Business Quant data.